AngioDynamics (ANGO -5.8%) takes a hit after its FQ2 earnings missed the mark across the board....
AngioDynamics (ANGO -5.8%) takes a hit after its FQ2 earnings missed the mark across the board. Profit fell 29% Y/Y, primarily due to costs related to a recall of some its NeverTouch procedure kits. Gross margin was also down, reflecting the impact of ongoing programs to reduce material costs and increase its manufacturing efficiency.
From other sites
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs